Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Editas Medicine Inc buy StockMargin50

Start price
€2.20
17.03.26 / 50%
Target price
-
17.04.26
Performance (%)
27.39%
End price
€2.80
17.04.26
Summary
This prediction ended on 17.04.26 with a price of €2.80. The prediction had a final performance of 27.39%. StockMargin50 has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Editas Medicine Inc 11.397% 11.397%
iShares Core DAX® 2.287% 9.963%
iShares Nasdaq 100 4.537% 8.787%
iShares Nikkei 225® 2.813% 14.081%
iShares S&P 500 3.096% 6.854%

Comments by StockMargin50 for this prediction

In the thread Trading Editas Medicine Inc
Prediction Buy
Perf. (%) 27.39%
Target price
Change
Ends at 17.04.26

Die von StockMargin50 gewählte maximale Laufzeit wurde überschritten